SS Innovations Gains Telesurgery Approvals in Indonesia, Philippines
TipRanks (Wed, 18-Mar 9:35 AM ET)
Globe Newswire (Wed, 18-Mar 8:30 AM ET)
SS Innovations Reports Fourth Quarter and Full Year 2025 Financial Results
Globe Newswire (Tue, 10-Mar 8:30 AM ET)
Globe Newswire (Mon, 9-Mar 8:30 AM ET)
SS Innovations Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2025
Globe Newswire (Tue, 13-Jan 8:30 AM ET)
SS Innovations Appoints Milan Rao as Global Chief Operating Officer and Chief Financial Officer
Globe Newswire (Thu, 8-Jan 5:00 PM ET)
Globe Newswire (Tue, 6-Jan 8:30 AM ET)
SS Innovations International Inc is a commercial-stage surgical robotics company. It designs, manufactures, and markets a surgical robotic system called the SSi Mantra Surgical Robotic System (the SSi Mantra) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic, and cardiac surgeries. Additionally, the company offers a suite of stapling, energy, and core instrumentation for its surgical systems, under the brand name of SSi Mudra.
SS Innovations Intl trades on the NASDAQ stock market under the symbol SSII.
As of March 20, 2026, SSII stock price declined to $4.94 with 58,774 million shares trading.
SSII has a beta of 0.57, meaning it tends to be less sensitive to market movements. SSII has a correlation of 0.00 to the broad based SPY ETF.
SSII has a market cap of $988.65 million. This is considered a Small Cap stock.
The top ETF exchange traded funds that SSII belongs to (by Net Assets): ISMD, EWX.
SSII support price is $4.65 and resistance is $5.37 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SSII shares will trade within this expected range on the day.